Though there are in-silico and in-vitro studies that associated the ITGB2 as one of the important genes in cancer, the exact mechanisms of how this gene promotes GBM remains elusive and worth to be investigated in the future [11, 54, 55]. This evidence concerns the gene ITGB2 and glioblastoma.